BioSpace News Archive

Jnana Therapeutics, a biotechnology company utilizing its next generation chemoproteomic platform to address well-validated but hard-to-drug targets, today announced that it has selected JNT-517 as a development candidate and a potential first-in-class oral approach for the treatment of phenylketonuria (PKU), a rare inherited metabolic disease.

Pieris Pharmaceuticals, Inc. today announced that it will host a full-year 2021 investor call on Tuesday, March 1, 2022 at 8:00 AM EST to discuss financial results and provide a corporate update.

Nascent Biotech, Inc. is pleased to announce that the Company has received a payment totaling USD $750,000 from BioRay Pharmaceutical, Ltd.

Videra Health, the asynchronous video and analytics healthcare platform, today announced the appointment of AI scientist, technologist and entrepreneur, Rana el Kaliouby, Ph.D., to its Board of Directors.

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s fourth quarter and full year 2021 financial results will be released after market close on Tuesday, March 1, 2022.

Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Vocera Communications, Inc. (NYSE: VCRA), a leader in digital care coordination and communication.

ARGEN-LT delivers the only continuous stability measurement for shelf-life studies at low temperature(s).

PacBio welcomes Michael Eberle, Ph.D., as Vice President of Computational Biology.

Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will report its full year 2021 financial results after market close on Thursday, March 10, 2022.

OsteoCentric Technologies, the pioneer of Mechanical Integration, announces the execution of a private label agreement with Altus Spine which will propel their subsidiary, OsteoCentric Spine, LLC, into the pedicle screw fixation space.